ATE339952T1 - Fluorchlorkohlenwasserstofffreie aerosolformulierungen - Google Patents

Fluorchlorkohlenwasserstofffreie aerosolformulierungen

Info

Publication number
ATE339952T1
ATE339952T1 AT02022987T AT02022987T ATE339952T1 AT E339952 T1 ATE339952 T1 AT E339952T1 AT 02022987 T AT02022987 T AT 02022987T AT 02022987 T AT02022987 T AT 02022987T AT E339952 T1 ATE339952 T1 AT E339952T1
Authority
AT
Austria
Prior art keywords
hydrochlorofluorocarbon
aerosol formulations
free aerosol
fatty acid
free
Prior art date
Application number
AT02022987T
Other languages
English (en)
Inventor
Julianne Berry
Imtiaz A Chaudry
Joel A Sequeira
Michael Kopcha
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24863572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE339952(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE339952T1 publication Critical patent/ATE339952T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT02022987T 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstofffreie aerosolformulierungen ATE339952T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71278991A 1991-06-10 1991-06-10

Publications (1)

Publication Number Publication Date
ATE339952T1 true ATE339952T1 (de) 2006-10-15

Family

ID=24863572

Family Applications (4)

Application Number Title Priority Date Filing Date
AT95101761T ATE203900T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstofffreie aerosolformulierungen
AT92913922T ATE132368T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstoffreie aerosolformulierungen
AT95101762T ATE226067T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstofffreie aerosolformulierungen
AT02022987T ATE339952T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstofffreie aerosolformulierungen

Family Applications Before (3)

Application Number Title Priority Date Filing Date
AT95101761T ATE203900T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstofffreie aerosolformulierungen
AT92913922T ATE132368T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstoffreie aerosolformulierungen
AT95101762T ATE226067T1 (de) 1991-06-10 1992-06-08 Fluorchlorkohlenwasserstofffreie aerosolformulierungen

Country Status (24)

Country Link
US (2) US6503482B1 (de)
EP (7) EP1277467B1 (de)
JP (1) JPH06508149A (de)
CN (1) CN1067579A (de)
AT (4) ATE203900T1 (de)
AU (1) AU2178992A (de)
CA (1) CA2111003A1 (de)
CZ (1) CZ271393A3 (de)
DE (4) DE69231991T2 (de)
DK (1) DK1277467T3 (de)
ES (3) ES2180592T3 (de)
FI (1) FI935463L (de)
HU (1) HUT67445A (de)
IE (1) IE921848A1 (de)
IL (1) IL102130A0 (de)
MX (1) MX9202751A (de)
NO (2) NO934499D0 (de)
NZ (1) NZ243062A (de)
OA (1) OA09827A (de)
PT (1) PT1277467E (de)
SK (1) SK140593A3 (de)
WO (1) WO1992022287A1 (de)
YU (1) YU59192A (de)
ZA (1) ZA924163B (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
DE69227257T2 (de) 1991-12-12 1999-03-25 Glaxo Group Ltd Arzneimittel
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
DE69205177T2 (de) * 1991-12-12 1996-03-21 Glaxo Group Ltd., Greenford, Middlesex Pharmazeutische Aerosolformulierung.
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
AU675633B2 (en) * 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
AU699677B2 (en) * 1992-07-31 1998-12-10 Glaxo Group Limited Surfactant free aerosol formulations containing beclomathasone dipropionate
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
DE69424181T2 (de) * 1993-12-20 2000-10-19 Minnesota Mining And Mfg. Co., Saint Paul Flunisolide aerosolformulierungen
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
WO1995024892A1 (en) * 1994-03-14 1995-09-21 Abbott Laboratories Aerosol drug formulations containing vitamin e
GB9405594D0 (en) * 1994-03-22 1994-05-11 Ici Plc Cooling compositions
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
CN1088580C (zh) * 1994-12-22 2002-08-07 阿斯特拉公司 气溶胶药物制剂
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
DE69731473T2 (de) 1996-05-09 2005-10-27 Amrad Operations Pty. Ltd., Richmond Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
CN1162157C (zh) * 1996-08-29 2004-08-18 先灵公司 无氯氟烃的糠酸莫米他松气溶胶制剂
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
ES2244008T3 (es) * 1996-12-04 2005-12-01 Link Products Limited Composiciones farmaceuticas y dispositivos para su administracion.
EP0966958A4 (de) * 1997-03-14 2001-10-10 Fujisawa Pharmaceutical Co Aerosol-präparation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
ES2172217T3 (es) * 1997-10-09 2002-09-16 Schering Corp Suspensiones de furoato de mometasona para nebulizacion.
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
ATE384001T1 (de) * 2002-08-27 2008-02-15 Schering Corp Verfahren zur herstellung von dosierinhalatorformulierungen
CN104505028B (zh) 2002-10-31 2017-10-31 株式会社半导体能源研究所 显示设备及其控制方法
DK1572622T3 (da) * 2002-12-10 2006-08-28 Sepracor Inc Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator
JP2007505136A (ja) * 2003-09-10 2007-03-08 マツプ・フアーマシユーテイカルズ・インコーポレーテツド ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
EP1925293A3 (de) * 2003-10-20 2010-01-13 Schering Corporation Pharmazeutische Aerosol-Zusammensetzungen
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
PT1711164E (pt) * 2004-01-21 2010-06-28 Schering Corp Método de tratamento da rinossinusite aguda
EP2522365B1 (de) 2004-11-24 2016-10-26 Meda Pharmaceuticals Inc. Zusammensetzungen aus Azelastin und Verwendungsverfahren dafür
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
WO2007020204A2 (en) * 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
EP1981545A2 (de) * 2006-02-09 2008-10-22 Schering Corporation Pharmazeutische formulierungen
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
CA2677838C (en) * 2007-02-11 2017-08-01 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
JP6374682B2 (ja) * 2013-09-09 2018-08-15 花王株式会社 筋萎縮抑制剤
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
US20210244896A1 (en) * 2018-06-13 2021-08-12 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (de) 1956-03-21 1900-01-01
US2885427A (en) 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US3320125A (en) 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
US3261748A (en) 1964-07-17 1966-07-19 Dow Chemical Co 1,1,1,2-tetrafluoroethane anesthetic
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
NL7708731A (nl) 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4129603A (en) 1978-02-07 1978-12-12 Imperial Chemical Industries Limited Manufacture of halogenated compounds
US4311863A (en) 1980-06-11 1982-01-19 E. I. Du Pont De Nemours & Company Process for the manufacture of 1,1,1,2-tetrafluoroethane
ATE8790T1 (de) 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
ES2038696T3 (es) * 1986-03-10 1996-07-16 Burghart Kurt Procedimiento para producir un preparado farmaceutico.
US4851595A (en) 1987-07-07 1989-07-25 E. I. Du Pont De Nemours And Company Liquid phase halogen exchange process for the manufacture of 1,1,1,2-tetrafluoroethane
US4967024A (en) 1988-06-23 1990-10-30 E. I. Du Pont De Nemours And Company Catalyzed hydrofluorination process
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828544D0 (en) 1988-12-07 1989-01-11 Ici Plc Chemical process
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
DE3905726A1 (de) 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
AU633584B2 (en) 1989-06-15 1993-02-04 Tokyo Tanabe Company Limited Aerosols of pyrido(1,2-a)pyrimidine compounds
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
ES2071306T3 (es) * 1990-03-23 1995-06-16 Minnesota Mining & Mfg El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
CA2086096A1 (en) * 1990-06-27 1991-12-28 Robert A. Moris Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
PT98105B (pt) 1990-06-28 1998-11-30 Glaxo Inc Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
DE69124374T2 (de) * 1990-06-29 1997-06-19 Fisons Plc, Ipswich, Suffolk Druckaerosolzusammensetzung
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
DE4038203A1 (de) * 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
US5474759A (en) * 1991-06-10 1995-12-12 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DE69227257T2 (de) 1991-12-12 1999-03-25 Glaxo Group Ltd Arzneimittel
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
AU675633B2 (en) 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants

Also Published As

Publication number Publication date
CA2111003A1 (en) 1992-12-23
EP1277467B1 (de) 2006-09-20
YU59192A (sh) 1994-12-28
DE69231991T2 (de) 2002-04-04
NO934499L (no) 1993-12-09
EP0653205B1 (de) 2002-10-16
EP1277467A2 (de) 2003-01-22
EP0518601A1 (de) 1992-12-16
IL102130A0 (en) 1993-01-14
DE69232818T2 (de) 2003-06-18
ES2158908T3 (es) 2001-09-16
JPH06508149A (ja) 1994-09-14
DE69207409D1 (de) 1996-02-15
DE69231991D1 (de) 2001-09-13
NO934499D0 (no) 1993-12-09
ATE203900T1 (de) 2001-08-15
PT1277467E (pt) 2006-12-29
FI935463A0 (fi) 1993-12-07
EP1005860A1 (de) 2000-06-07
EP0587790A1 (de) 1994-03-23
DE69232818D1 (de) 2002-11-21
EP0656205B1 (de) 2001-08-08
FI935463A7 (fi) 1993-12-07
DK1277467T3 (da) 2007-01-15
ATE226067T1 (de) 2002-11-15
EP0587790B2 (de) 2000-03-08
NZ243062A (en) 1993-09-27
CZ271393A3 (en) 1994-07-13
DE69233659D1 (de) 2006-11-02
ATE132368T1 (de) 1996-01-15
HUT67445A (en) 1995-04-28
ES2180592T3 (es) 2003-02-16
MX9202751A (es) 1992-12-01
ES2269582T3 (es) 2007-04-01
ZA924163B (en) 1993-02-24
WO1992022287A1 (en) 1992-12-23
AU2178992A (en) 1993-01-12
DE69233659T2 (de) 2007-09-13
EP0656205A1 (de) 1995-06-07
OA09827A (en) 1994-04-15
FI935463L (fi) 1993-12-07
US6503482B1 (en) 2003-01-07
SK140593A3 (en) 1994-11-09
IE921848A1 (en) 1992-12-16
EP0653205A1 (de) 1995-05-17
EP1736147A3 (de) 2007-10-17
EP1736147A2 (de) 2006-12-27
EP1277467A3 (de) 2003-04-16
US6416743B1 (en) 2002-07-09
EP0587790B1 (de) 1996-01-03
CN1067579A (zh) 1993-01-06

Similar Documents

Publication Publication Date Title
ATE203900T1 (de) Fluorchlorkohlenwasserstofffreie aerosolformulierungen
ES2158910T3 (es) Formulaciones en aerosol sin clorofluorocarbonos.
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
DE69316760D1 (de) Oberflächenaktivmittelfreie aerosolformulierungen enthaltend beclomethason dipropionat
DE69711637D1 (de) Aerosolformulierungen
AU601176B2 (en) Benzodiazepine aerosols
SE9000441D0 (sv) Novel cyclosporin galenic forms
AU547175B2 (en) Stabilised prostaglandin formulations
ZA898331B (en) Pharmaceutical compositions
DK0657164T3 (da) Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid
ATE117200T1 (de) Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.
SE8104657L (sv) Injicerbara farmaceutiska kompositioner
CA2141039A1 (en) Surfactant free aerosol formulations containing beclomethasone dipropionate
GR900100076A (en) Preparation method of novel pharmaceutical forms of cyclosporine
IT1245730B (it) Composizioni farmaceutiche stabili a base di calcitonina somministrabili per via nasale
JPS53112835A (en) Novel hydroxybenzoic ester and antiseptic agent containing the same as effective ingredient

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1277467

Country of ref document: EP